FIELD: medicine.
SUBSTANCE: invention refers to medicine. A method involves a reproducible ADMA-like gestosis model in pregnant female rats Wistar by the daily 7-day intraperitoneal introduction of L-nitro-arginine-methyl ester 25 mg/kg. This daily 7-day intraperitoneal introduction is combined with the intragastric introduction of the antibacterial preparation Azythromycin 30 mg/kg/day of the group of macrolides.
EFFECT: method is effective for correction of placental microcirculation disorder.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PLACENTAL MICROCIRCULATION DISORDER CORRECTION WITH POLYVITAMIN-MINERAL COMPLEX IN ADMA-LIKE GESTOSIS MODELS IN EXPERIMENT | 2011 |
|
RU2457548C1 |
METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION WITH POLYVITAMIN-MINERAL COMPLEX IN ADMA-LIKE GESTOSIS MODELS IN EXPERIMENT | 2011 |
|
RU2460149C1 |
METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION WITH AZITHROMYCIN IN ADMA-LIKE GESTOSIS MODEL IN EXPERIMENT | 2012 |
|
RU2507595C2 |
METHOD FOR PLACENTAL MICROCIRCULATION CORRECTION BY RECOMBINANT ERYTHROPOIETIN IN ADMA-LIKE GESTOSIS MODEL | 2011 |
|
RU2466462C1 |
METHOD FOR PLACENTAL MICROCIRCULATION DISORDER CORRECTION IN ADMA-LIKE GESTOSIS MODELS IN EXPERIMENT | 2010 |
|
RU2432618C1 |
METHOD FOR PLACENTAL MICROCIRCULATION DISORDER CORRECTION IN ADMA-LIKE GESTOSIS MODEL | 2010 |
|
RU2453000C1 |
METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION OF PHARMACOLOGICAL PRE-CONDITIONING BY NICORANDIL IN SIMULATED ADMA-LIKE GESTOSIS EXPERIMENTALLY | 2014 |
|
RU2543359C1 |
METHOD OF CORRECTION OF PLACENTAL MICROCIRCULATION DISORDERS WITH 2-HYDROXYPHENYLTHIOACETAMIDE DERIVATIVES | 2019 |
|
RU2721554C1 |
METHOD FOR PLACENTAL MICROCIRCULATION DISORDER CORRECTION IN ADMA-LIKE GESTOSIS MODELS IN EXPERIMENT BY SINGLE ISCHEMIC EPISODE | 2011 |
|
RU2481103C1 |
METHOD FOR CORRECTION OF PLACENTAL MICROCIRCULATION DISORDER BY ARGINASE II INHIBITOR | 2016 |
|
RU2644271C1 |
Authors
Dates
2012-09-27—Published
2011-08-31—Filed